IntelliCell BioSciences Inc:企業の戦略的SWOT分析

◆英語タイトル:IntelliCell BioSciences Inc - Strategic SWOT Analysis Review
◆商品コード:SWOT20MY2461
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

IntelliCell BioSciences Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

IntelliCell BioSciences Inc (IntelliCell BioSciences) is a regenerative medicine company. The company’s flagship IntelliCell patented technology helps extract, separate and process stromal vascular fraction (SVF) cells from the blood vessels in adult adipose (fat) tissue. SVF cells derived from a body’s fat can be used to treat ailments or rejuvenate diseased or damaged tissue and cell functions. IntelliCell BioSciences also carries out the development of autologous and allogeneic cells from living and non-living tissue donors for research purposes. It identified technologies and laboratory processes to develop products and services in personalized medicine for the regeneration, prevention, and cure of age related disease states. IntelliCell BioSciences is headquartered in New York, the US.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
IntelliCell BioSciences Inc – Key Facts
IntelliCell BioSciences Inc – Key Employees
IntelliCell BioSciences Inc – Key Employee Biographies
IntelliCell BioSciences Inc – Major Products and Services
IntelliCell BioSciences Inc – History
IntelliCell BioSciences Inc – Company Statement
IntelliCell BioSciences Inc – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
IntelliCell BioSciences Inc – Business Description
IntelliCell BioSciences Inc – Corporate Strategy
IntelliCell BioSciences Inc – SWOT Analysis
SWOT Analysis – Overview
IntelliCell BioSciences Inc – Strengths
IntelliCell BioSciences Inc – Weaknesses
IntelliCell BioSciences Inc – Opportunities
IntelliCell BioSciences Inc – Threats
IntelliCell BioSciences Inc – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
IntelliCell BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
IntelliCell BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
IntelliCell BioSciences Inc, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
IntelliCell BioSciences Inc, Key Facts
IntelliCell BioSciences Inc, Key Employees
IntelliCell BioSciences Inc, Key Employee Biographies
IntelliCell BioSciences Inc, Major Products and Services
IntelliCell BioSciences Inc, History
IntelliCell BioSciences Inc, Key Competitors
IntelliCell BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
IntelliCell BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
IntelliCell BioSciences Inc, Recent Deals Summary

List of Figures
IntelliCell BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
IntelliCell BioSciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[IntelliCell BioSciences Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • First Pacific Company Limited:企業の戦略・SWOT・財務分析
    First Pacific Company Limited - Strategy, SWOT and Corporate Finance Report Summary First Pacific Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Banca Monte dei Paschi di Siena SpA:企業のM&A・事業提携・投資動向
    Banca Monte dei Paschi di Siena SpA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banca Monte dei Paschi di Siena SpA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • Och-Ziff Capital Management Group LLC (OZM):企業の財務・戦略的SWOT分析
    Summary Och-Ziff Capital Management Group LLC (Oz Management) is an alternative asset management firm that provides asset management services. The firm’s services portfolio includes portfolio management, private investments, funds management, and equity funds investment and management services. Its …
  • Suzuken Co Ltd (9987):企業の財務・戦略的SWOT分析
    Suzuken Co Ltd (9987) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sysmex America Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sysmex America Inc (Sysmex America), a subsidiary of Sysmex Corp is a medical device company that manufactures laboratory testing equipments. The company's products include clinical diagnostic devices, in vitro diagnostic hematology devices, urinalysis devices, reagents and information syste …
  • Endocyte Inc (ECYT):製薬・医療:M&Aディール及び事業提携情報
    Summary Endocyte Inc (Endocyte) is a biopharmaceutical company that develops targeted therapies for the treatment of cancer and inflammatory diseases. The company’s pipeline products include Lu-PSMA-617 and Ac-PSMA-617 for radiologand therapy, and FITC CAR-T. Endocyte's proprietary small molecule dr …
  • General Dynamics Corporation:企業の戦略・SWOT・財務情報
    General Dynamics Corporation - Strategy, SWOT and Corporate Finance Report Summary General Dynamics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Aohata Corporation:企業の戦略・SWOT・財務分析
    Aohata Corporation - Strategy, SWOT and Corporate Finance Report Summary Aohata Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Gladstone Institutes:製薬・医療:M&Aディール及び事業提携情報
    Summary Gladstone Institutes (Gladstone) is a non-profit life science research organization that offers medical research programs. The organization carries out research and development in the areas of cardiovascular disease, virology and immunology, neurological disease, stem cell biology and regene …
  • Spotless Group Holdings Ltd:企業の戦略・SWOT・財務分析
    Spotless Group Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Spotless Group Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • UGE International Ltd (UGE):企業の財務・戦略的SWOT分析
    Summary UGE International Ltd (UGE), formerly Way Ventures Inc, is a renewable energy company that operates through wind, solar, solar-wind technologies. The company offers products such as electronics and accessories, wind turbines, solar panels, energy storage systems, mounting system, electronics …
  • BASF SE (BAS)-石油・ガス分野:企業M&A・提携分析
    Summary BASF SE (BASF) is a chemical company, which carries out research and development (R&D), production, marketing and sales of chemicals, plastics, crop protection products, and performance products. Its product line comprises solvents, adhesives, surfactant, organic chemicals, fuel additives, e …
  • Dome Energy AB (DOME):石油・ガス:M&Aディール及び事業提携情報
    Summary Dome Energy AB (Dome Energy), formerly Commodity Quest AB is an oil and gas company that exploits, explores, develops and produces conventional oil and gas reserves. The company explores for onshore oil and gas fields to identify unexploited well locations. It explores and produces oil and g …
  • TTEC Holdings Inc (TTEC):企業の財務・戦略的SWOT分析
    TTEC Holdings Inc (TTEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cathay Pacific Airways Limited:企業のM&A・事業提携・投資動向
    Cathay Pacific Airways Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cathay Pacific Airways Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • China State Shipbuilding Corp:企業の戦略・SWOT・財務情報
    China State Shipbuilding Corp - Strategy, SWOT and Corporate Finance Report Summary China State Shipbuilding Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • SOGAZ Insurance Group:企業の戦略・SWOT・財務分析
    SOGAZ Insurance Group - Strategy, SWOT and Corporate Finance Report Summary SOGAZ Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Xspray Pharma AB (XSPRAY):製薬・医療:M&Aディール及び事業提携情報
    Summary Xspray Pharma AB (Xspray Pharma), formerly Xspray Microparticles AB, is a drug development company that develops and commercializes protein kinase inhibitors (PKI) for targeted cancer treatments. The company’s drug candidates include HyNap-Dasa, HyNap-Nilo and HyNap-Sora. Its protein kinase …
  • Consort Medical plc (CSRT):医療機器:M&Aディール及び事業提携情報
    Summary Consort Medical plc (Consort Medical) is a contract development and manufacturing organization (CDMO) with focus on medical device technologies for drug delivery. It develops, manufactures and markets high volume disposable medical devices for drug delivery and point-of-care (POC) diagnostic …
  • Innergex Renewable Energy Inc (INE):電力:M&Aディール及び事業提携情報
    Summary Innergex Renewable Energy Inc (Innergex) is an independent renewable power producer. It develops, acquires, owns and operates hydroelectric facilities, wind farms, and solar photovoltaic geothermal power facilities. Through long-term power purchase agreements, the company sells electricity t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆